PYC Therapeutics (ASX:PYC) has announced a significant step in its board renewal process, appointing former Woodside chief executive Peter Coleman as its new Independent Non-Executive Chair, effective immediately after the company’s Annual General Meeting on 18 November 2025. …
PYC Therapeutics appoints Peter Coleman as new Chair as part of board renewal
November 13, 2025 Australian BiotechBioPharmaDispatch Executive
Latest Video
New Stories
-
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News -
Australia's 2026 flu vaccination season barely moves the needle on uptake
September 15, 2026 - - Latest News -
Persistent fatigue could be an overlooked sign of liver disease
September 15, 2026 - - Latest News -
Noxopharm moves lupus skin therapy toward next human trial
September 14, 2026 - - Australian Biotech -
Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends
September 14, 2026 - - Latest News -
Diabetes and cancer blood tests reach WA and NT patients under new Healius deal
September 14, 2026 - - Australian Biotech -
FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug
September 14, 2026 - - Australian Biotech